Close

Ratings by Citi (Yigal Nochomovitz)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/27/2023 Rain Therapeutics RAIN Maintain Buy
(N/A)
 
 
  Details
1/9/2023 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
1/6/2023 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
12/29/2022 Ardelyx, Inc ARDX Maintain Buy
(N/A)
 
 
  Details
12/23/2022 ProQR Therapeutics N.V. PRQR Maintain Neutral
(N/A)
 
 
  Details
12/14/2022 Cellectis CLLS Maintain Buy
(N/A)
 
 
  Details
12/8/2022 Mirati Therapeutics MRTX Downgrade Neutral
(Buy)
49.59
(52.50)
5.87% Details
12/5/2022 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
12/2/2022 Rigel Pharmaceuticals RIGL Upgrade Buy
(Neutral)
0.68
(1.70)
150% Details
11/28/2022 NuCana NCNA Maintain Buy
(N/A)
 
 
  Details
11/23/2022 Rain Therapeutics RAIN Maintain Buy
(N/A)
 
 
  Details
11/23/2022 MacroGenics MGNX Downgrade Neutral
(Buy)
6.18
(5.87)
-5.02% Details
11/23/2022 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
11/23/2022 Caribou Biosciences Inc. CRBU Maintain Buy
(N/A)
 
 
  Details
11/23/2022 Arcus Biosciences RCUS Maintain Buy
(N/A)
 
 
  Details
11/22/2022 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
11/22/2022 Ardelyx, Inc ARDX Maintain Buy
(N/A)
 
 
  Details
11/22/2022 Aldeyra Therapeutics ALDX Maintain Buy
(N/A)
 
 
  Details
11/17/2022 Ardelyx, Inc ARDX Maintain Buy
(N/A)
 
 
  Details
11/15/2022 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
11/15/2022 Merus N.V. MRUS Maintain Buy
(N/A)
 
 
  Details
11/15/2022 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
11/11/2022 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
11/8/2022 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
11/7/2022 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
11/3/2022 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
11/3/2022 Arcturus Therapeutics ARCT Upgrade Buy
(Neutral)
21.69
(22.24)
2.54% Details
10/14/2022 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
10/14/2022 ProKidney PROK New Coverage Buy
(N/A)
10.25
(10.59)
3.32% Details
9/22/2022 Gracell Biotechnologies Inc GRCL New Coverage Buy
(N/A)
2.30
(2.23)
-3.04% Details
9/16/2022 Opthea Ltd. OPT Maintain Buy
(N/A)
 
 
  Details
9/16/2022 Innate Pharma S.A. IPHA Maintain Buy
(N/A)
 
 
  Details
8/29/2022 Ovid Therapeutics Inc OVID Maintain Neutral
(N/A)
 
 
  Details
8/29/2022 Aerie Pharma AERI Downgrade Neutral
(Buy)
15.10
(15.25)
0.99% Details
8/26/2022 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
8/26/2022 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
8/26/2022 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
8/26/2022 Caribou Biosciences Inc. CRBU Maintain Buy
(N/A)
 
 
  Details
8/18/2022 Cellectis CLLS Maintain Buy
(N/A)
 
 
  Details
8/18/2022 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
8/18/2022 Ardelyx, Inc ARDX Maintain Buy
(N/A)
 
 
  Details
8/18/2022 Arcus Biosciences RCUS Maintain Buy
(N/A)
 
 
  Details
8/17/2022 Merus N.V. MRUS Maintain Buy
(N/A)
 
 
  Details
8/17/2022 Applied Therapeutics APLT Maintain Buy
(N/A)
 
 
  Details
8/15/2022 Unity Biotechnology Inc UBX Maintain Buy
(N/A)
 
 
  Details
8/10/2022 Arcturus Therapeutics ARCT Maintain Neutral
(N/A)
 
 
  Details
8/9/2022 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
8/4/2022 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
8/2/2022 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
8/1/2022 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
7/20/2022 Atara Biotherapeutics ATRA Downgrade Sell
(Neutral)
3.64
(5.49)
50.82% Details
7/19/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
7/7/2022 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
6/9/2022 Aldeyra Therapeutics ALDX Maintain Buy
(N/A)
 
 
  Details
6/9/2022 Rigel Pharmaceuticals RIGL Downgrade Neutral
(Buy)
1.76
(0.68)
-61.36% Details
6/1/2022 Shattuck Labs STTK New Coverage Buy
(N/A)
2.72
(4.23)
55.51% Details
5/20/2022 Ovid Therapeutics Inc OVID Maintain Neutral
(N/A)
 
 
  Details
5/20/2022 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
5/20/2022 Applied Therapeutics APLT Maintain Buy
(N/A)
 
 
  Details
5/19/2022 Merus N.V. MRUS Maintain Buy
(N/A)
 
 
  Details
5/17/2022 Unity Biotechnology Inc UBX Maintain Buy
(N/A)
 
 
  Details
5/16/2022 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
5/12/2022 Caribou Biosciences Inc. CRBU Maintain Buy
(N/A)
 
 
  Details
5/12/2022 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
5/10/2022 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
5/9/2022 Atara Biotherapeutics ATRA Downgrade Neutral
(Buy)
6.92
(3.64)
-47.4% Details
4/21/2022 Arcturus Therapeutics ARCT Downgrade Neutral
(Buy)
25.26
(21.69)
-14.13% Details
4/8/2022 Innate Pharma S.A. IPHA Maintain Buy
(N/A)
 
 
  Details
4/8/2022 Caribou Biosciences Inc. CRBU Maintain Buy
(N/A)
 
 
  Details
4/5/2022 Imara Inc. IMRA Downgrade Neutral
(Buy)
1.63
(5.05)
209.82% Details
3/16/2022 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
3/4/2022 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
3/4/2022 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
3/4/2022 NuCana NCNA Maintain Buy
(N/A)
 
 
  Details
2/28/2022 MacroGenics MGNX Upgrade Buy
(Neutral)
9.67
(5.87)
-39.3% Details
2/14/2022 ProQR Therapeutics N.V. PRQR Downgrade Neutral
(Buy)
5.64
(2.97)
-47.34% Details
12/21/2021 Aldeyra Therapeutics ALDX Maintain Buy
(N/A)
 
 
  Details
12/20/2021 Calliditas Therapeutics CALT Maintain Buy
(N/A)
 
 
  Details
12/20/2021 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
12/17/2021 Calliditas Therapeutics CALT Maintain Buy
(N/A)
 
 
  Details
12/15/2021 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
12/3/2021 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
12/3/2021 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
12/3/2021 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
11/30/2021 Ardelyx, Inc ARDX Maintain Buy
(N/A)
 
 
  Details
11/24/2021 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
11/19/2021 Arcus Biosciences RCUS Maintain Buy
(N/A)
 
 
  Details
11/17/2021 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
11/15/2021 Caribou Biosciences Inc. CRBU Upgrade Buy
(Neutral)
20.52
(7.39)
-63.99% Details
11/9/2021 Fate Therapeutics FATE Upgrade Buy
(Neutral)
61.42
(6.74)
-89.03% Details
10/11/2021 Merus N.V. MRUS Maintain Buy
(N/A)
 
 
  Details
9/28/2021 Harpoon Therapeutics HARP Upgrade Buy
(Neutral)
7.96
(1.05)
-86.81% Details
9/28/2021 Puma Biotechnology PBYI Upgrade Buy
(Neutral)
6.82
(4.57)
-32.99% Details
9/22/2021 Innate Pharma S.A. IPHA Maintain Buy
(N/A)
 
 
  Details
9/8/2021 Applied Therapeutics APLT Maintain Buy
(N/A)
 
 
  Details
8/30/2021 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
8/25/2021 Arcturus Therapeutics ARCT Maintain Buy
(N/A)
 
 
  Details
8/17/2021 Caribou Biosciences Inc. CRBU New Coverage Neutral
(N/A)
26.48
(7.39)
-72.09% Details
8/13/2021 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
8/13/2021 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
8/13/2021 Dicerna Pharmaceuticals DRNA Maintain Buy
(N/A)
 
 
  Details
8/11/2021 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
8/9/2021 Arcus Biosciences RCUS Maintain Buy
(N/A)
 
 
  Details
8/9/2021 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
8/9/2021 Dicerna Pharmaceuticals DRNA Downgrade Neutral
(Buy)
37.92
(38.22)
0.79% Details
7/23/2021 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
6/28/2021 Unity Biotechnology Inc UBX Upgrade Buy
(Sell)
4.34
(5.07)
16.82% Details
6/14/2021 CRISPR Therapeutics CRSP Upgrade Neutral
(Sell)
123.71
(55.33)
-55.27% Details
6/8/2021 Harpoon Therapeutics HARP Downgrade Neutral
(Buy)
15.27
(7.96)
-47.87% Details
6/7/2021 Merus N.V. MRUS Upgrade Buy
(Neutral)
20.68
(16.64)
-19.54% Details
6/4/2021 Mirati Therapeutics MRTX Upgrade Buy
(Neutral)
154.86
(49.59)
-67.98% Details
5/26/2021 Puma Biotechnology PBYI Maintain Neutral
(N/A)
 
 
  Details
5/25/2021 Syndax Pharmaceuticals SNDX New Coverage Buy
(N/A)
17.69
(26.84)
51.72% Details
5/21/2021 CRISPR Therapeutics CRSP Maintain Sell
(N/A)
 
 
  Details
5/21/2021 Arcus Biosciences RCUS Maintain Buy
(N/A)
 
 
  Details
5/20/2021 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
5/12/2021 Imara Inc. IMRA New Coverage Buy
(N/A)
7.46
(5.05)
-32.31% Details
5/11/2021 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
5/6/2021 Ultragenyx Pharma RARE Upgrade Buy
(Neutral)
101.85
(45.71)
-55.12% Details
3/25/2021 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
3/4/2021 Ovid Therapeutics Inc OVID Maintain Neutral
(N/A)
 
 
  Details
3/2/2021 Atara Biotherapeutics ATRA Upgrade Buy
(Neutral)
17.10
(5.49)
-67.89% Details
3/1/2021 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
2/16/2021 Unity Biotechnology Inc UBX Downgrade Sell
(Neutral)
8.28
(5.07)
-38.77% Details
2/11/2021 Fate Therapeutics FATE Downgrade Neutral
(Buy)
103.31
(6.74)
-93.48% Details
1/28/2021 Zymeworks ZYME Upgrade Buy
(Neutral)
44.06
(9.82)
-77.71% Details
1/25/2021 Zymeworks ZYME Downgrade Neutral
(Buy)
52.16
(9.82)
-81.17% Details
1/15/2021 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
1/14/2021 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
1/8/2021 Aldeyra Therapeutics ALDX Maintain Buy
(N/A)
 
 
  Details
12/15/2020 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
12/14/2020 Arcturus Therapeutics ARCT Maintain Buy
(N/A)
 
 
  Details
12/9/2020 Atara Biotherapeutics ATRA Downgrade Neutral
(Buy)
26.23
(17.10)
-34.81% Details
12/8/2020 Lexicon Pharmaceuticals LXRX Upgrade Buy
(Neutral)
1.58
(2.40)
51.9% Details
12/7/2020 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
12/2/2020 Ovid Therapeutics Inc OVID Downgrade Neutral
(Buy)
6.84
(2.43)
-64.47% Details
11/25/2020 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
11/23/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
11/11/2020 Dicerna Pharmaceuticals DRNA Maintain Buy
(N/A)
 
 
  Details
11/11/2020 Cellectis CLLS Maintain Buy
(N/A)
 
 
  Details
11/10/2020 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
11/9/2020 Aerie Pharma AERI Maintain Buy
(N/A)
 
 
  Details
11/9/2020 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
10/28/2020 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
10/6/2020 Arcturus Therapeutics ARCT New Coverage Buy
(N/A)
49.97
(22.24)
-55.49% Details
9/18/2020 Mirati Therapeutics MRTX Downgrade Neutral
(Buy)
161.97
(52.50)
-67.59% Details
8/19/2020 Cellectis CLLS Upgrade Buy
(Buy)
17.22
(2.60)
-84.9% Details
8/18/2020 Unity Biotechnology Inc UBX Downgrade Neutral
(Buy)
12.43
(5.07)
-59.21% Details
8/17/2020 Imara Inc. IMRA Upgrade Buy
(Neutral)
20.61
(5.05)
-75.5% Details
8/11/2020 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
8/10/2020 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
8/3/2020 MacroGenics MGNX Downgrade Neutral
(Buy)
26.75
(5.87)
-78.06% Details
7/13/2020 Rigel Pharmaceuticals RIGL Maintain Buy
(N/A)
 
 
  Details
6/30/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
6/30/2020 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
6/30/2020 Imara Inc. IMRA Downgrade Neutral
(Buy)
34.23
(5.05)
-85.25% Details
6/26/2020 Translate Bio TBIO Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Unity Biotechnology Inc UBX Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
6/2/2020 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
6/2/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
6/1/2020 Arvinas Inc. ARVN Upgrade Buy
(Neutral)
44.85
(34.59)
-22.88% Details
5/8/2020 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
5/8/2020 Aerie Pharma AERI Maintain Buy
(N/A)
 
 
  Details
5/5/2020 Portola Pharmaceuticals PTLA Downgrade Neutral
(Buy)
7.76
(18.03)
132.35% Details
4/28/2020 Lexicon Pharmaceuticals LXRX Maintain Neutral
(N/A)
 
 
  Details
4/28/2020 Lexicon Pharmaceuticals LXRX Maintain Neutral
(N/A)
 
 
  Details
4/23/2020 Atara Biotherapeutics ATRA Upgrade Buy
(Neutral)
8.00
(5.49)
-31.38% Details
4/6/2020 Imara Inc. IMRA New Coverage Buy
(N/A)
15.75
(5.05)
-67.94% Details
3/31/2020 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
3/16/2020 Lexicon Pharmaceuticals LXRX Maintain Neutral
(N/A)
 
 
  Details
3/12/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
3/4/2020 CRISPR Therapeutics CRSP Maintain Sell
(N/A)
 
 
  Details
3/2/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
2/26/2020 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
2/24/2020 Aerie Pharma AERI Maintain Buy
(N/A)
 
 
  Details
2/12/2020 Ardelyx, Inc ARDX New Coverage Buy
(N/A)
7.33
(3.26)
-55.53% Details
1/28/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
1/24/2020 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
1/21/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
1/13/2020 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
1/13/2020 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
1/9/2020 Applied Therapeutics APLT Maintain Buy
(N/A)
 
 
  Details
1/8/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
1/7/2020 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
12/29/2019 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
12/19/2019 Aerie Pharma AERI New Coverage Buy
(N/A)
21.92
(15.25)
-30.43% Details
12/18/2019 Dicerna Pharmaceuticals DRNA Maintain Buy
(N/A)
 
 
  Details
12/2/2019 Galera Therapeutics GRTX New Coverage Buy
(N/A)
12.53
(2.44)
-80.53% Details
11/19/2019 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
11/18/2019 Ovid Therapeutics Inc OVID Maintain Buy
(N/A)
 
 
  Details
11/18/2019 CRISPR Therapeutics CRSP Maintain Sell
(N/A)
 
 
  Details
11/8/2019 Lexicon Pharmaceuticals LXRX Downgrade Neutral
(Buy)
3.88
(2.40)
-38.14% Details
11/7/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
11/7/2019 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
10/15/2019 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
10/11/2019 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
10/9/2019 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
9/24/2019 Ovid Therapeutics Inc OVID Maintain Buy
(N/A)
 
 
  Details
9/17/2019 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
9/10/2019 Translate Bio TBIO Maintain Buy
(N/A)
 
 
  Details
9/4/2019 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
8/27/2019 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
8/21/2019 NuCana NCNA Maintain Buy
()
 
 
  Details
8/21/2019 Synlogic Inc. SYBX Downgrade Sell
(Buy)
4.83
(0.90)
-81.37% Details
8/12/2019 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
8/12/2019 Atara Biotherapeutics ATRA Maintain Neutral
(N/A)
 
 
  Details
8/8/2019 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
8/8/2019 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
8/7/2019 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
8/7/2019 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
8/5/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
7/30/2019 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
7/3/2019 Dicerna Pharmaceuticals DRNA Maintain Buy
(Buy)
 
 
  Details
6/26/2019 Aldeyra Therapeutics ALDX Maintain Buy
(N/A)
 
 
  Details
6/26/2019 Eiger BioPharma EIGR New Coverage Buy
(N/A)
10.61
(2.09)
-80.3% Details
6/13/2019 Synlogic Inc. SYBX Maintain Buy
(N/A)
 
 
  Details
6/7/2019 Puma Biotechnology PBYI Maintain Neutral
(N/A)
 
 
  Details
6/5/2019 Arvinas Inc. ARVN Downgrade Neutral
(Buy)
20.05
(44.85)
123.69% Details
6/4/2019 Mirati Therapeutics MRTX Upgrade Buy
(Neutral)
89.20
(52.50)
-41.14% Details
6/4/2019 Atara Biotherapeutics ATRA Upgrade Neutral
(Sell)
22.21
(5.49)
-75.28% Details
5/24/2019 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
5/24/2019 Cellectis CLLS New Coverage Neutral
(N/A)
18.34
(2.60)
-85.82% Details
5/24/2019 Acceleron Pharma XLRN New Coverage Buy
(N/A)
43.25
(178.75)
313.29% Details
5/24/2019 Arcus Biosciences RCUS New Coverage Buy
(N/A)
9.52
(20.51)
115.44% Details
5/15/2019 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
5/13/2019 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
5/10/2019 Puma Biotechnology PBYI Downgrade Neutral
(Buy)
30.02
(6.82)
-77.28% Details
5/2/2019 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
4/18/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
3/21/2019 Merus N.V. MRUS Maintain Neutral
(N/A)
 
 
  Details
3/20/2019 Akebia Therapeutics AKBA New Coverage Neutral
(N/A)
8.17
(1.08)
-86.78% Details
3/15/2019 Merus N.V. MRUS Maintain Neutral
(N/A)
 
 
  Details
3/15/2019 Ovid Therapeutics Inc OVID Maintain Buy
(N/A)
 
 
  Details
3/15/2019 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
3/6/2019 Chimerix CMRX Maintain Neutral
(N/A)
 
 
  Details
3/4/2019 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
3/4/2019 Puma Biotechnology PBYI Maintain Buy
(N/A)
 
 
  Details
3/4/2019 Portola Pharmaceuticals PTLA Maintain Buy
(Buy)
 
 
  Details
3/4/2019 Mirati Therapeutics MRTX Downgrade Neutral
(Buy)
72.80
(89.20)
22.53% Details
3/1/2019 Puma Biotechnology PBYI Maintain Buy
(N/A)
 
 
  Details
2/21/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
2/20/2019 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
2/20/2019 ProQR Therapeutics N.V. PRQR Maintain Buy
(N/A)
 
 
  Details
2/7/2019 MacroGenics MGNX Upgrade Buy
(Sell)
11.11
(5.87)
-47.16% Details
2/4/2019 MacroGenics MGNX Downgrade Sell
(Neutral)
11.73
(11.11)
-5.29% Details
1/24/2019 Rigel Pharmaceuticals RIGL Maintain Buy
(N/A)
 
 
  Details
1/22/2019 CRISPR Therapeutics CRSP Downgrade Sell
(Neutral)
37.13
(55.33)
49.02% Details
1/18/2019 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
1/2/2019 Merus N.V. MRUS Maintain Neutral
(N/A)
 
 
  Details
12/6/2018 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
12/4/2018 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
12/4/2018 Aldeyra Therapeutics ALDX New Coverage Buy
(N/A)
8.97
(6.19)
-30.99% Details
11/27/2018 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
11/27/2018 LOXO Maintain Buy
(N/A)
 
 
  Details
11/16/2018 Rigel Pharmaceuticals RIGL Maintain Buy
(N/A)
 
 
  Details
11/15/2018 ProQR Therapeutics N.V. PRQR New Coverage Buy
(N/A)
18.67
(2.97)
-84.09% Details
11/9/2018 Chimerix CMRX Maintain Neutral
(N/A)
 
 
  Details
11/8/2018 Ultragenyx Pharma RARE Upgrade Neutral
(Sell)
54.34
(45.71)
-15.88% Details
11/7/2018 Portola Pharmaceuticals PTLA Maintain Buy
(N/A)
 
 
  Details
11/5/2018 Puma Biotechnology PBYI Maintain Buy
(N/A)
 
 
  Details
11/2/2018 Lexicon Pharmaceuticals LXRX Maintain Buy
(N/A)
 
 
  Details
10/29/2018 Ultragenyx Pharma RARE Maintain Sell
(N/A)
 
 
  Details
10/22/2018 Arvinas Inc. ARVN New Coverage Buy
(N/A)
15.56
(20.05)
28.86% Details
9/28/2018 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
9/18/2018 Puma Biotechnology PBYI Maintain Buy
(N/A)
 
 
  Details
9/14/2018 Zai Lab ZLAB Maintain Buy
(N/A)
 
 
  Details
9/5/2018 Synlogic Inc. SYBX Maintain Buy
(N/A)
 
 
  Details
8/27/2018 Rigel Pharmaceuticals RIGL New Coverage Buy
(N/A)
2.80
(1.70)
-39.29% Details
8/24/2018 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
8/24/2018 Synlogic Inc. SYBX Upgrade Buy
(Neutral)
7.91
(4.83)
-38.94% Details